ScholarIQanswers from OpenAlex
National Institute of Allergy and Infectious Diseases
FunderResearch funding and supported work
National Institute of Allergy and Infectious Diseases is a funder indexed in ScholarIQ from OpenAlex.
What is known about National Institute of Allergy and Infectious Diseases?
ScholarIQrecord summary
US research institute for the treatment and prevention of infectious diseases
How many works does National Institute of Allergy and Infectious Diseases have?
ScholarIQindexed works
National Institute of Allergy and Infectious Diseases has 387,975 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for National Institute of Allergy and Infectious Diseases?
ScholarIQopenalex
The OpenAlex for National Institute of Allergy and Infectious Diseases is on the source record.
What is the ROR of National Institute of Allergy and Infectious Diseases?
ScholarIQror
The ROR for National Institute of Allergy and Infectious Diseases is on the source record.
What are the most-cited papers on National Institute of Allergy and Infectious Diseases?
ScholarIQmost cited works
Stigma, housing and identity after prison
Danya E. Keene, Amy B. Smoyer, Kim M. Blankenship
Familial aggregation of food allergy and sensitization to food allergens: a family‐based study
Hui‐Ju Tsai, Rajesh Kumar, Jacqueline A. Pongracic, X. Liu, R. Story, Yanni Yu, Deanna Caruso, J. Costello, A. Schroeder, Yuqi Fang, Hakan Demirtaş, K.E. Meyer, Maurice R.G. O’Gorman, X. Wang
Perfluoroalkyl substances and ovarian hormone concentrations in naturally cycling women
Emily S. Barrett, Chongshu Chen, Sally W. Thurston, Line Småstuen Haug, Azemira Sabaredzovic, Frøydis Fjeldheim, Hanne Frydenberg, Susan F. Lipson, Peter T. Ellison, Inger Thune
Prevalence and Severity of Sesame Allergy in the United States
Christopher Warren, Avneet S. Chadha, Scott H. Sicherer, Jialing Jiang, Ruchi S. Gupta
Correlates and Consequences of an Acute Change in eGFR in Response to the SGLT2 Inhibitor Dapagliflozin in Patients with CKD
Niels Jongs, Glenn M. Chertow, Tom Greene, John J.V. McMurray, Anna Maria Langkilde, Ricardo Correa‐Rotter, Naoki Kashihara, Peter Rossing, C. David Sjöström, Bergur V. Stefánsson, Robert D. Toto, David C. Wheeler, Hiddo J.L. Heerspink